Surmodics Cash on Hand 2010-2025 | SRDX

Surmodics cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Surmodics Annual Cash on Hand
(Millions of US $)
2024 $40
2023 $45
2022 $19
2021 $39
2020 $61
2019 $55
2018 $65
2017 $48
2016 $47
2015 $56
2014 $47
2013 $26
2012 $30
2011 $38
2010 $20
2009 $21
Surmodics Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $31
2024-12-31 $30
2024-09-30 $40
2024-06-30 $38
2024-03-31 $41
2023-12-31 $35
2023-09-30 $45
2023-06-30 $45
2023-03-31 $19
2022-12-31 $26
2022-09-30 $19
2022-06-30 $22
2022-03-31 $27
2021-12-31 $32
2021-09-30 $39
2021-06-30 $68
2021-03-31 $66
2020-12-31 $54
2020-09-30 $61
2020-06-30 $61
2020-03-31 $48
2019-12-31 $48
2019-09-30 $55
2019-06-30 $45
2019-03-31 $46
2018-12-31 $46
2018-09-30 $65
2018-06-30 $62
2018-03-31 $66
2017-12-31 $47
2017-09-30 $48
2017-06-30 $44
2017-03-31 $46
2016-12-31 $45
2016-09-30 $47
2016-06-30 $44
2016-03-31 $40
2015-12-31 $43
2015-09-30 $56
2015-06-30 $54
2015-03-31 $49
2014-12-31 $31
2014-09-30 $47
2014-06-30 $41
2014-03-31 $34
2013-12-31 $23
2013-09-30 $26
2013-06-30 $28
2013-03-31 $36
2012-12-31 $31
2012-09-30 $30
2012-06-30 $79
2012-03-31 $74
2011-12-31 $63
2011-09-30 $38
2011-06-30 $34
2011-03-31 $27
2010-12-31 $24
2010-09-30 $20
2010-06-30 $22
2010-03-31 $19
2009-12-31 $19
2009-09-30 $21
2009-06-30 $22
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.456B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.750B 25.66
Boston Scientific (BSX) United States $152.620B 38.21
Stryker (SYK) United States $150.824B 31.54
EssilorLuxottica (ESLOY) France $131.932B 0.00
Medtronic (MDT) Ireland $117.545B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.596B 0.00
Haleon (HLN) United Kingdom $43.351B 24.74
ResMed (RMD) United States $39.208B 29.45
GE HealthCare Technologies (GEHC) United States $35.024B 16.63
Agilent Technologies (A) United States $33.005B 21.52
Koninklijke Philips (PHG) Netherlands $24.092B 16.91
Terumo (TRUMY) Japan $23.645B 30.71
Insulet (PODD) United States $20.097B 78.89
Zimmer Biomet Holdings (ZBH) United States $19.096B 12.26
Baxter (BAX) United States $14.117B 10.54
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.680B 23.25
Lantheus Holdings (LNTH) United States $5.005B 12.62
Perrigo (PRGO) Ireland $3.788B 9.60
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Haemonetics (HAE) United States $3.565B 16.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.397B 28.23
ICU Medical (ICUI) United States $3.107B 22.91
LeMaitre Vascular (LMAT) United States $1.816B 40.60
QuidelOrtho (QDEL) United States $1.727B 11.88
AtriCure (ATRC) United States $1.454B 0.00
Acuren (TIC) United States $1.435B 0.00
AdaptHealth (AHCO) United States $1.279B 12.99
Green Thumb Industries (GTBIF) United States $1.243B 27.96
Phibro Animal Health (PAHC) United States $1.185B 15.15
Neogen (NEOG) United States $1.090B 13.94
BioLife Solutions (BLFS) United States $1.024B 0.00
InMode (INMD) Israel $0.911B 9.18
Kestra Medical Technologies (KMTS) United States $0.874B 0.00
Tilray Brands (TLRY) Canada $0.791B 0.00
Curaleaf Holdings (CURLF) Canada $0.784B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.644B 0.00
Owens & Minor (OMI) United States $0.626B 5.19
Evolus (EOLS) United States $0.617B 0.00
CeriBell (CBLL) United States $0.561B 0.00
Valneva SE (VALN) France $0.530B 0.00
ZimVie (ZIMV) United States $0.522B 23.71
SNDL (SNDL) Canada $0.431B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
VAREX IMAGING (VREX) United States $0.312B 11.48
Cresco Labs (CRLBF) United States $0.307B 0.00
Sanuwave Health (SNWV) United States $0.303B 0.00
Capricor Therapeutics (CAPR) United States $0.298B 0.00
Aurora Cannabis (ACB) Canada $0.284B 84.17
Quanterix (QTRX) United States $0.275B 0.00
Cerus (CERS) United States $0.273B 0.00
OraSure Technologies (OSUR) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.67
Canopy Growth (CGC) Canada $0.256B 0.00
Sanara MedTech (SMTI) United States $0.234B 0.00
Brainsway (BWAY) Israel $0.229B 60.50
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.220B 0.00
Omeros (OMER) United States $0.219B 0.00
Organigram Global (OGI) Canada $0.208B 0.00
High Tide (HITI) Canada $0.195B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
TriSalus Life Sciences (TLSI) United States $0.170B 0.00
Vireo Growth (VREOF) United States $0.153B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.124B 15.32
TerrAscend (TSNDF) Canada $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.099B 12.77
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Jushi Holdings (JUSHF) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Veru (VERU) United States $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Zynex (ZYXI) United States $0.074B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
United-Guardian (UG) United States $0.044B 15.11
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.14
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00